Briefing document

Access: What Novartis Says . . . And Why It's Wrong

February 14, 2012

Read Novartis's statements on its generic medicines court case, and learn why they're wrong.

Briefing document

Q&A: Patents in India and the Novartis Case

February 14, 2012

Learn more about why Novartis is taking India to court over the production of affordable generic medicines.

Briefing document

Access: The Novartis Drop the Case Campaign

February 14, 2012

Novartis is taking India to court to stop production of affordable generic medicines that millions of people depend on to stay alive.

Briefing document

Background on the EU-India FTA

February 08, 2012

Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.

Briefing document

The Truth Behind the Spin: How the Europe-India Free Trade Agreement Will Harm Access to Medicines

November 04, 2010

The crucial role India plays in supplying the developing world with affordable quality medicines is being threatened.

Briefing document

Europe! HANDS OFF Our Medicine

October 07, 2010

Millions of people in developing countries rely on affordable generic medicines produced in countries including India to stay alive. But the European Commission is pushing aggressive policies that will severely restrict people’s access to these lifesaving medicines.